Medical Innovation Exchange

Pfizer's phase 3 maternal RSV vaccine trial hits at interim review, prompting early stop and race to FDA

https://www.fiercebiotech.com/biotech/pfizers-phase-3-maternal-rsv-vaccine-trial-hits-interim-review-prompting-early-stop-and

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!